144 related articles for article (PubMed ID: 37004837)
1. Prognostic radiomic signature for head and neck cancer: Development and validation on a multi-centric MRI dataset.
Bologna M; Corino V; Cavalieri S; Calareso G; Gazzani SE; Poli T; Ravanelli M; Mattavelli D; de Graaf P; Nauta I; Scheckenbach K; Licitra L; Mainardi L
Radiother Oncol; 2023 Jun; 183():109638. PubMed ID: 37004837
[TBL] [Abstract][Full Text] [Related]
2. MRI-based radiomic prognostic signature for locally advanced oral cavity squamous cell carcinoma: development, testing and comparison with genomic prognostic signatures.
Corti A; De Cecco L; Cavalieri S; Lenoci D; Pistore F; Calareso G; Mattavelli D; de Graaf P; Leemans CR; Brakenhoff RH; Ravanelli M; Poli T; Licitra L; Corino V; Mainardi L
Biomark Res; 2023 Jul; 11(1):69. PubMed ID: 37455307
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients.
Alfieri S; Romanò R; Bologna M; Calareso G; Corino V; Mirabile A; Ferri A; Bellanti L; Poli T; Marcantoni A; Grosso E; Tarsitano A; Battaglia S; Blengio F; De Martino I; Valerini S; Vecchio S; Richetti A; Deantonio L; Martucci F; Grammatica A; Ravanelli M; Ibrahim T; Caruso D; Locati LD; Orlandi E; Bossi P; Mainardi L; Licitra LF
Acta Oncol; 2021 Sep; 60(9):1192-1200. PubMed ID: 34038324
[TBL] [Abstract][Full Text] [Related]
4. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric MRI-Based Radiomic Signature for Preoperative Evaluation of Overall Survival in Intrahepatic Cholangiocarcinoma After Partial Hepatectomy.
Yang Y; Zou X; Zhou W; Yuan G; Hu D; Kuang D; Shen Y; Xie Q; Zhang Q; Hu X; Li Z
J Magn Reson Imaging; 2022 Sep; 56(3):739-751. PubMed ID: 35049076
[TBL] [Abstract][Full Text] [Related]
6. MRI-based radiomic signature as predictive marker for patients with head and neck squamous cell carcinoma.
Yuan Y; Ren J; Shi Y; Tao X
Eur J Radiol; 2019 Aug; 117():193-198. PubMed ID: 31307647
[TBL] [Abstract][Full Text] [Related]
7. Methodology and technology for the development of a prognostic MRI-based radiomic model for the outcome of head and neck cancer patients.
Bologna M; Corino V; Tenconi C; Facchinetti N; Calareso G; Iacovelli N; Cavallo A; Alfieri S; Cavalieri S; Fallai C; Valdagni R; Rancati T; Trama A; Licitra L; Orlandi E; Mainardi L
Annu Int Conf IEEE Eng Med Biol Soc; 2020 Jul; 2020():1152-1155. PubMed ID: 33018191
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging based radiomics prediction of Human Papillomavirus infection status and overall survival in oropharyngeal squamous cell carcinoma.
Boot PA; Mes SW; de Bloeme CM; Martens RM; Leemans CR; Boellaard R; van de Wiel MA; de Graaf P
Oral Oncol; 2023 Feb; 137():106307. PubMed ID: 36657208
[TBL] [Abstract][Full Text] [Related]
9. Radiomics signature extracted from diffusion-weighted magnetic resonance imaging predicts outcomes in osteosarcoma.
Zhao S; Su Y; Duan J; Qiu Q; Ge X; Wang A; Yin Y
J Bone Oncol; 2019 Dec; 19():100263. PubMed ID: 31667064
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study.
Yu Y; He Z; Ouyang J; Tan Y; Chen Y; Gu Y; Mao L; Ren W; Wang J; Lin L; Wu Z; Liu J; Ou Q; Hu Q; Li A; Chen K; Li C; Lu N; Li X; Su F; Liu Q; Xie C; Yao H
EBioMedicine; 2021 Jul; 69():103460. PubMed ID: 34233259
[TBL] [Abstract][Full Text] [Related]
12. Novel radiomic signature as a prognostic biomarker for locally advanced rectal cancer.
Meng Y; Zhang Y; Dong D; Li C; Liang X; Zhang C; Wan L; Zhao X; Xu K; Zhou C; Tian J; Zhang H
J Magn Reson Imaging; 2018 Feb; ():. PubMed ID: 29437271
[TBL] [Abstract][Full Text] [Related]
13. Radiomic Features Associated With HPV Status on Pretreatment Computed Tomography in Oropharyngeal Squamous Cell Carcinoma Inform Clinical Prognosis.
Song B; Yang K; Garneau J; Lu C; Li L; Lee J; Stock S; Braman NM; Koyuncu CF; Toro P; Fu P; Koyfman SA; Lewis JS; Madabhushi A
Front Oncol; 2021; 11():744250. PubMed ID: 34557418
[TBL] [Abstract][Full Text] [Related]
14. Improving survival prediction of high-grade glioma via machine learning techniques based on MRI radiomic, genetic and clinical risk factors.
Tan Y; Mu W; Wang XC; Yang GQ; Gillies RJ; Zhang H
Eur J Radiol; 2019 Nov; 120():108609. PubMed ID: 31606714
[TBL] [Abstract][Full Text] [Related]
15. Association of MRI-derived radiomic biomarker with disease-free survival in patients with early-stage cervical cancer.
Fang J; Zhang B; Wang S; Jin Y; Wang F; Ding Y; Chen Q; Chen L; Li Y; Li M; Chen Z; Liu L; Liu Z; Tian J; Zhang S
Theranostics; 2020; 10(5):2284-2292. PubMed ID: 32089742
[TBL] [Abstract][Full Text] [Related]
16. Radiomic signature: A novel magnetic resonance imaging-based prognostic biomarker in patients with skull base chordoma.
Wei W; Wang K; Liu Z; Tian K; Wang L; Du J; Ma J; Wang S; Li L; Zhao R; Cui L; Wu Z; Tian J
Radiother Oncol; 2019 Dec; 141():239-246. PubMed ID: 31668985
[TBL] [Abstract][Full Text] [Related]
17. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
[TBL] [Abstract][Full Text] [Related]
18. Radiomic signature of
Jiang Y; Yuan Q; Lv W; Xi S; Huang W; Sun Z; Chen H; Zhao L; Liu W; Hu Y; Lu L; Ma J; Li T; Yu J; Wang Q; Li G
Theranostics; 2018; 8(21):5915-5928. PubMed ID: 30613271
[TBL] [Abstract][Full Text] [Related]
19. Predicting Disease-Free Survival With Multiparametric MRI-Derived Radiomic Signature in Cervical Cancer Patients Underwent CCRT.
Liu B; Sun Z; Xu ZL; Zhao HL; Wen DD; Li YA; Zhang F; Hou BX; Huan Y; Wei LC; Zheng MW
Front Oncol; 2021; 11():812993. PubMed ID: 35145910
[TBL] [Abstract][Full Text] [Related]
20. T2-weighted MRI radiomics in high-grade intramedullary osteosarcoma: predictive accuracy in assessing histologic response to chemotherapy, overall survival, and disease-free survival.
White LM; Atinga A; Naraghi AM; Lajkosz K; Wunder JS; Ferguson P; Tsoi K; Griffin A; Haider M
Skeletal Radiol; 2023 Mar; 52(3):553-564. PubMed ID: 35778618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
